Osteomyelitis: Recent advances in pathophysiology and therapeutic strategies

Journal of Orthopaedics

Volumn 14, Issue 1, 2017, Pages 45-52

  Birt, Mitchell C ^a   Anderson, David W ^a   Bruce Toby, E ^a   Wang, Jinxi ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

Antibiotic; Arthroplasty; Bone infection; Fracture; Osteomyelitis

Indexed keywords

ANTIBIOTIC AGENT; ANTIBIOTIC BONE CEMENT; COLLAGEN SPONGE; GENTAMICIN; POLY(METHYL METHACRYLATE); POLYCAPROLACTONE; POLYGLACTIN; POLYGLYCOLIC ACID; POLYLACTIC ACID; SILVER; TOBRAMYCIN; VANCOMYCIN;

ANTIBIOTIC THERAPY; ARTHROPLASTY; BIOACTIVE GLASS; BIOFILM; BONE INFECTION; BONE REGENERATION; CEMENT SPACER; CHEMICAL PHENOMENA; CONTROLLED RELEASE FORMULATION; DEBRIDEMENT; DEVICE THERAPY; DISEASE ASSOCIATION; DRUG DELIVERY SYSTEM; EARLY DIAGNOSIS; EXOTHERMICITY; HUMAN; IMMUNOTHERAPY; INFECTION PREVENTION; MECHANICS; NONHUMAN; OPEN FRACTURE; ORTHOPEDIC IMPLANT; OSTEOMYELITIS; PATHOPHYSIOLOGY; PERIPROSTHETIC JOINT INFECTION; POSTTRAUMATIC COMPLICATION; PRIORITY JOURNAL; PROSTHETIC REPLACEMENT; REVIEW; SURGICAL DRAINAGE; TISSUE SCAFFOLD; TREATMENT PLANNING; WOUND IRRIGATION;

EID: 84993958623     PISSN: None     EISSN: 0972978X     Source Type: Journal    
DOI: 10.1016/j.jor.2016.10.004     Document Type: Review

References (99)

1. 1 Shirwaiker, R.A., Springer, B.D., Spangehl, M.J., et al. A clinical perspective on musculoskeletal infection treatment strategies and challenges. J Am Acad Orthop Surg 23:suppl (2015), S44–S54.
2. 2 Lew, D.P., Waldvogel, F.A., Osteomyelitis. N Engl J Med 336 (1997), 999–1007.
3. 3 Rosenberg, A.E., Bones, joints, and soft-tissue tumors. Kumar, V., Abbas, A.K., Fausto, N., Aster, J.C., (eds.) Robbins and Cotran Pathologic Basis of Disease, 8th ed., 2010, Philadelphia Saunders Elsevier, 1205–1256.
4. 4 Mouzopoulos, G., Kanakaris, N.K., Kontakis, G., Obakponovwe, O., Townsend, R., Giannoudis, P.V., Management of bone infections in adults: the surgeon's and microbiologist's perspectives. Injury 42:suppl 5 (2011), S18–S23.
5. 5 Bozic, K.J., Kamath, A.F., Ong, K., et al. Comparative epidemiology of revision arthroplasty: failed THA poses greater clinical and economic burdens than failed TKA. Clin Orthop Relat Res 473 (2015), 2131–2138.
6. 6 Kurtz, S.M., Lau, E., Watson, H., Schmier, J.K., Parvizi, J., Economic burden of periprosthetic joint infection in the United States. J Arthroplasty, 27, 2012 61–5.e1.
7. 7 Martinez-Pastor, J.C., Macule-Beneyto, F., Suso-Vergara, S., Acute infection in total knee arthroplasty: diagnosis and treatment. Open Orthop J 7 (2013), 197–204.
8. 8 Yoon, B.H., Ha, Y.C., Lee, Y.K., Koo, K.H., Postoperative deep infection after cemented versus cementless total hip arthroplasty: a meta-analysis. J Arthroplasty 30 (2015), 1823–1827.
9. 9 Choi, H.R., Bedair, H., Mortality following revision total knee arthroplasty: a matched cohort study of septic versus aseptic revisions. J Arthroplasty 29 (2014), 1216–1218.
10. 10 Kamath, A.F., Ong, K.L., Lau, E., et al. Quantifying the burden of revision total joint arthroplasty for periprosthetic infection. J Arthroplasty 30 (2015), 1492–1497.
11. 11 Mack, A.W., Groth, A.T., Frisch, H.M., Doukas, W.C., Treatment of open periarticular shoulder fractures sustained in combat-related injuries. Am J Orthop 37 (2008), 130–135.
12. 12 Chen, A.T., Vallier, H.A., Noncontiguous and open fractures of the lower extremity: epidemiology, complications, and unplanned procedures. Injury 47 (2016), 742–747.
13. 13 Pollak, A.N., Jones, A.L., Castillo, R.C., Bosse, M.J., MacKenzie, E.J., The relationship between time to surgical debridement and incidence of infection after open high-energy lower extremity trauma. J Bone Jt Surg Am 92 (2010), 7–15.
14. 14 Roussignol, X., Sigonney, G., Potage, D., Etienne, M., Duparc, F., Dujardin, F., Secondary nailing after external fixation for tibial shaft fracture: risk factors for union and infection. A 55 case series. Orthop Traumatol Surg Res: OTSR 101 (2015), 89–92.
15. 15 Court-Brown, C.M., Keating, J.F., McQueen, M.M., Infection after intramedullary nailing of the tibia. Incidence and protocol for management. J Bone Jt Surg Br 74 (1992), 770–774.
16. 16 Kremers, H.M., Nwojo, M.E., Ransom, J.E., Wood-Wentz, C.M., Melton, L.J. 3rd, Huddleston, P.M. 3rd, Trends in the epidemiology of osteomyelitis: a population-based study, 1969 to 2009. J Bone Jt Surg Am Vol 97 (2015), 837–845.
17. 17 Ovaska, M.T., Makinen, T.J., Madanat, R., et al. Risk factors for deep surgical site infection following operative treatment of ankle fractures. J Bone Jt Surg Am 95 (2013), 348–353.
18. 18 Lew, D.P., Waldvogel, F.A., Osteomyelitis. Lancet 364 (2004), 369–379.
19. 19 Paakkonen, M., Kallio, M.J., Peltola, H., Kallio, P.E., Antibiotic treatment and surgery for acute hematogenous calcaneal osteomyelitis of childhood. J Foot Ankle Surg 54 (2015), 840–843.
20. 20 Francis, J.R., Robson, J., Wong, D., et al. Chronic recurrent multifocal Q fever osteomyelitis in children: an emerging clinical challenge. Pediatr Infect Dis J, 2016.
21. 21 SooHoo, N.F., Krenek, L., Eagan, M.J., Gurbani, B., Ko, C.Y., Zingmond, D.S., Complication rates following open reduction and internal fixation of ankle fractures. J Bone Jt Surg 91 (2009), 1042–1049.
22. 22 Yousefi, F., Nabipour, I., Kalantarhormozi, M., Assadi, T., Raeisi, A., Assadi, M., Quantum dot-based diabetic foot mapping for diagnosing osteomyelitis and Charcot neuroarthropathy. Med Hypotheses 85 (2015), 7–9.
23. 23 Lowy, F.D., Hammer, S.M., Staphylococcus epidermidis infections. Ann Intern Med 99 (1983), 834–839.
24. 24 Tong, S.Y., Davis, J.S., Eichenberger, E., Holland, T.L., Fowler, V.G. Jr., Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev 28 (2015), 603–661.
25. 25 Benito, N., Franco, M., Coll, P., et al. Etiology of surgical site infections after primary total joint arthroplasties. J Orthop Res 32 (2014), 633–637.
26. 26 Lamagni, T., Elgohari, S., Harrington, P., Trends in surgical site infections following orthopaedic surgery. Curr Opin Infect Dis 28 (2015), 125–132.
27. 27 Rodriguez-Pardo, D., Pigrau, C., Lora-Tamayo, J., et al. Gram-negative prosthetic joint infection: outcome of a debridement, antibiotics and implant retention approach. A large multicentre study. Clin Microbiol Infect 20 (2014), O911–O919.
28. 28 Trampuz, A., Zimmerli, W., Antimicrobial agents in orthopaedic surgery: prophylaxis and treatment. Drugs 66 (2006), 1089–1105.
29. 29 Bedair, H., Goyal, N., Dietz, M.J., et al. A history of treated periprosthetic joint infection increases the risk of subsequent different site infection. Clin Orthop Relat Res 473 (2015), 2300–2304.
30. 30 Parvizi, J., Zmistowski, B., Berbari, E.F., et al. New definition for periprosthetic joint infection: from the Workgroup of the Musculoskeletal Infection Society. Clin Orthop Relat Res 469 (2011), 2992–2994.
31. 31 Zmistowski, B., Della Valle, C., Bauer, T.W., et al. Diagnosis of periprosthetic joint infection. J Arthroplasty 29 (2014), 77–83.
32. 32 Moojen, D.J., Spijkers, S.N., Schot, C.S., et al. Identification of orthopaedic infections using broad-range polymerase chain reaction and reverse line blot hybridization. J Bone Jt Surg Am 89 (2007), 1298–1305.
33. 33 Nelson, C.L., McLaren, A.C., McLaren, S.G., Johnson, J.W., Smeltzer, M.S., Is aseptic loosening truly aseptic?. Clin Orthop Relat Res, 2005, 25–30.
34. 34 Belt, H.v.d., Neut, D., Schenk, W., Horn, J.R.v., Mei, H.C.v.d., Busscher, H.J., Infection of orthopedic implants and the use of antibiotic-loaded bone cements: a review. Acta Orthop Scand 72 (2001), 557–571.
35. 35 Thompson, S., Townsend, R., Pharmacological agents for soft tissue and bone infected with MRSA: which agent and for how long?. Injury 42:suppl 5 (2011), S7–S10.
36. 36 Williams, R.J., Henderson, B., Nair, S.P., Staphylococcus aureus fibronectin binding proteins A and B possess a second fibronectin binding region that may have biological relevance to bone tissues. Calcif Tissue Int 70 (2002), 416–421.
37. 37 Ribeiro, M., Monteiro, F.J., Ferraz, M.P., Infection of orthopedic implants with emphasis on bacterial adhesion process and techniques used in studying bacterial-material interactions. Biomatter 2 (2012), 176–194.
38. 38 Kalita, S.J., Verma, S., Nanocrystalline hydroxyapatite bioceramic using microwave radiation: synthesis and characterization. Mater Sci Eng: C 30 (2010), 295–303.
39. 39 Donlan, R.M., Biofilms: microbial life on surfaces. Emerg Infect Dis 8 (2002), 881–890.
40. 40 Li, Y.H., Lau, P.C., Lee, J.H., Ellen, R.P., Cvitkovitch, D.G., Natural genetic transformation of Streptococcus mutans growing in biofilms. J Bacteriol 183 (2001), 897–908.
41. 41 Garzoni, C., Kelley, W.L., Return of the Trojan horse: intracellular phenotype switching and immune evasion by Staphylococcus aureus. EMBO Mol Med 3 (2011), 115–117.
42. 42 Bera, A., Biswas, R., Herbert, S., Gotz, F., The presence of peptidoglycan O-acetyltransferase in various staphylococcal species correlates with lysozyme resistance and pathogenicity. Infect Immun 74 (2006), 4598–4604.
43. 43 Proctor, R.A., von Eiff, C., Kahl, B.C., et al. Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infections. Nat Rev Microbiol 4 (2006), 295–305.
44. 44 Sendi, P., Proctor, R.A., Staphylococcus aureus as an intracellular pathogen: the role of small colony variants. Trends Microbiol 17 (2009), 54–58.
45. 45 Bose, D., Kugan, R., Stubbs, D., McNally, M., Management of infected nonunion of the long bones by a multidisciplinary team. Bone Jt J 97-b (2015), 814–817.
46. 46 Lovati, A.B., Romano, C.L., Bottagisio, M., et al. Modeling Staphylococcus epidermidis-induced non-unions: subclinical and clinical evidence in rats. PLOS ONE, 11, 2016, e0147447.
47. 47 Sethi, S., Thormann, U., Sommer, U., et al. Impact of prophylactic CpG Oligodeoxynucleotide application on implant-associated Staphylococcus aureus bone infection. Bone 78 (2015), 194–202.
48. 48 Bedair, H., Ting, N., Bozic, K.J., Della Valle, C.J., Sporer, S.M., Treatment of early postoperative infections after THA: a decision analysis. Clin Orthop Relat Res 469 (2011), 3477–3485.
49. 49 Webb, N.D., McCanless, J.D., Courtney, H.S., Bumgardner, J.D., Haggard, W.O., Daptomycin eluted from calcium sulfate appears effective against Staphylococcus. Clin Orthop Relat Res 466 (2008), 1383–1387.
50. 50 Chang, Y., Chen, W.C., Hsieh, P.H., et al. In vitro activities of daptomycin-, vancomycin-, and teicoplanin-loaded polymethylmethacrylate against methicillin-susceptible, methicillin-resistant, and vancomycin-intermediate strains of Staphylococcus aureus. Antimicrob Agents Chemother 55 (2011), 5480–5484.
51. 51 Traub, W.H., Leonhard, B., Heat stability of the antimicrobial activity of sixty-two antibacterial agents. J Antimicrob Chemother 35 (1995), 149–154.
52. 52 Hanssen, A.D., Spangehl, M.J., Practical applications of antibiotic-loaded bone cement for treatment of infected joint replacements. Clin Orthop 427 (2004), 79–85.
53. 53 Zilberman, M., Elsner, J.J., Antibiotic-eluting medical devices for various applications. J Control Release 130 (2008), 202–215.
54. 54 Castelli, C.C., Gotti, V., Ferrari, R., Two-stage treatment of infected total knee arthroplasty: two to thirteen year experience using an articulating preformed spacer. Int Orthop 38 (2014), 405–412.
55. 55 Kohl, S., Evangelopoulos, D.S., Kohlhof, H., et al. An intraoperatively moulded PMMA prostheses like spacer for two-stage revision of infected total knee arthroplasty. Knee 18 (2011), 464–469.
56. 56 Lewis, G., Alternative acrylic bone cement formulations for cemented arthroplasties: present status, key issues, and future prospects. J Biomed Mater Res B: Appl Biomater 84 (2008), 301–319.
57. 57 Lewis, G., van Hooy-Corstjens, C.S., Bhattaram, A., Koole, L.H., Influence of the radiopacifier in an acrylic bone cement on its mechanical, thermal, and physical properties: barium sulfate-containing cement versus iodine-containing cement. J Biomed Mater Res B: Appl Biomater 73 (2005), 77–87.
58. 58 Kamimura, M., Tamura, J., Shinzato, S., et al. Interfacial tensile strength between polymethylmethacrylate-based bioactive bone cements and bone. J Biomed Mater Res 61 (2002), 564–571.
59. 59 Peebles, D.J., Ellis, R.H., Stride, S.D., Simpson, B.R., Cardiovascular effects of methylmethacrylate cement. Br Med J 1 (1972), 349–351.
60. 60 Donaldson, A.J., Thomson, H.E., Harper, N.J., Kenny, N.W., Bone cement implantation syndrome. Br J Anaesth 102 (2009), 12–22.
61. 61 DiCicco, M., Duong, T., Chu, A., Jansen, S.A., Tobramycin and gentamycin elution analysis between two in situ polymerizable orthopedic composites. J Biomed Mater Res B: Appl Biomater 65 (2003), 137–149.
62. 62 Boyd, D., Towler, M.R., Wren, A., Clarkin, O.M., Comparison of an experimental bone cement with surgical Simplex P, Spineplex and Cortoss. J Mater Sci Mater Med 19 (2008), 1745–1752.
63. 63 Palussiere, J., Berge, J., Gangi, A., et al. Clinical results of an open prospective study of a bis-GMA composite in percutaneous vertebral augmentation. Eur Spine J 14 (2005), 982–991.
64. 64 Eick, J.D., Barragan-Adjemian, C., Rosser, J., et al. Silorane resin supports proliferation, differentiation, and mineralization of MLO-A5 bone cells in vitro and bone formation in vivo. J Biomed Mater Res B: Appl Biomater 100 (2012), 850–861.
65. 65 Oga, M., Sugioka, Y., Hobgood, C.D., Gristina, A.G., Myrvik, Q.N., Surgical biomaterials and differential colonization by Staphylococcus epidermidis. Biomaterials 9 (1988), 285–289.
66. 66 Vaudaux, P., Suzuki, R., Waldvogel, F.A., Morgenthaler, J.J., Nydegger, U.E., Foreign body infection: role of fibronectin as a ligand for the adherence of Staphylococcus aureus. J Infect Dis 150 (1984), 546–553.
67. 67 Burd, T.A., Anglen, J.O., Lowry, K.J., Hendricks, K.J., Day, D., In vitro elution of tobramycin from bioabsorbable polycaprolactone beads. J Orthop Trauma 15 (2001), 424–428.
68. 68 Hendricks, K.J., Lane, D., Burd, T.A., et al. Elution characteristics of tobramycin from polycaprolactone in a rabbit model. Clin Orthop Relat Res, 2001, 418–426.
69. 69 El-Husseiny, M., Patel, S., MacFarlane, R.J., Haddad, F.S., Biodegradable antibiotic delivery systems. J Bone Jt Surg Br 93 (2011), 151–157.
70. 70 McLaren, A.C., Alternative materials to acrylic bone cement for delivery of depot antibiotics in orthopaedic infections. Clin Orthop Relat Res, 2004, 101–106.
71. 71 Wafa, H., Grimer, R.J., Reddy, K., et al. Retrospective evaluation of the incidence of early periprosthetic infection with silver-treated endoprostheses in high-risk patients: case–control study. Bone Jt J 97-b (2015), 252–257.
72. 72 Eto, S., Kawano, S., Someya, S., Miyamoto, H., Sonohata, M., Mawatari, M., First clinical experience with thermal-sprayed silver oxide-containing hydroxyapatite coating implant. J Arthroplasty 31 (2016), 1498–1503.
73. 73 Nooeaid, P., Li, W., Roether, J.A., et al. Development of bioactive glass based scaffolds for controlled antibiotic release in bone tissue engineering via biodegradable polymer layered coating. Biointerphases, 9, 2014, 041001.
74. 74 Pishbin, F., Mourino, V., Flor, S., et al. Electrophoretic deposition of gentamicin-loaded bioactive glass/chitosan composite coatings for orthopaedic implants. ACS Appl Mater Interfaces 6 (2014), 8796–8806.
75. 75 Rahaman, M.N., Bal, B.S., Huang, W., Review: emerging developments in the use of bioactive glasses for treating infected prosthetic joints. Mater Sci Eng C: Mater Biol Appl 41 (2014), 224–231.
76. 76 Profeta, A.C., Emerging developments in the use of bioactive glass for reconstruction of craniofacial bone. Br J Oral Maxillofac Surg 53 (2015), 760–762.
77. 77 Camargo, A.F., Baptista, A.M., Natalino, R., de Camargo, O.P., Bioactive glass in cavitary bone defects: a comparative experimental study in rabbits. Acta Ortop Bras 23 (2015), 202–207.
78. 78 Perez-Tanoira, R., Kinnari, T.J., Hyyrynen, T., et al. Effects of S53P4 bioactive glass on osteoblastic cell and biomaterial surface interaction. J Mater Sci Mater Med, 26, 2015, 246.
79. 79 Zhang, X., Jia, W., Gu, Y., et al. Teicoplanin-loaded borate bioactive glass implants for treating chronic bone infection in a rabbit tibia osteomyelitis model. Biomaterials 31 (2010), 5865–5874.
80. 80 Hofmann, G.O., Bar, T., Buhren, V., The osteosynthesis implant and early postoperative infection: healing with or without removal of the material?. Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen 68 (1997), 1175–1180.
81. 81 Rightmire, E., Zurakowski, D., Vrahas, M., Acute infections after fracture repair: management with hardware in place. Clin Orthop 466 (2008), 466–472.
82. 82 Parkkinen, M., Madanat, R., Lindahl, J., Makinen, T.J., Risk factors for deep infection following plate fixation of proximal tibial fractures. J Bone Jt Surg Am 98 (2016), 1292–1297.
83. 83 Conway, J.D., Hlad, L.M., Bark, S.E., Antibiotic cement-coated plates for management of infected fractures. Am J Orthop 44 (2015), E49–E53.
84. 84 Chan, Y.S., Ueng, S.W., Wang, C.J., Lee, S.S., Chao, E.K., Shin, C.H., Management of small infected tibial defects with antibiotic-impregnated autogenic cancellous bone grafting. J Trauma 45 (1998), 758–764.
85. 85 Chan, Y.S., Ueng, S.W., Wang, C.J., Lee, S.S., Chen, C.Y., Shin, C.H., Antibiotic-impregnated autogenic cancellous bone grafting is an effective and safe method for the management of small infected tibial defects: a comparison study. J Trauma 48 (2000), 246–255.
86. 86 Cierny, G. 3rd, Mader, J.T., Penninck, J.J., A clinical staging system for adult osteomyelitis. Clin Orthop Relat Res, 2003, 7–24.
87. 87 Mader, J.T., Shirtliff, M., Calhoun, J.H., Staging and staging application in osteomyelitis. Clin Infect Dis 25 (1997), 1303–1309.
88. 88 Calhoun, J.H., Manring, M.M., Shirtliff, M., Osteomyelitis of the long bones. Semin Plast Surg 23 (2009), 59–72.
89. 89 Jacqueline, C., Caillon, J., Impact of bacterial biofilm on the treatment of prosthetic joint infections. J Antimicrob Chemother 69:suppl 1 (2014), i37–i40.
90. 90 Liu, C.I., Liu, G.Y., Song, Y., et al. A cholesterol biosynthesis inhibitor blocks Staphylococcus aureus virulence. Science (New York, NY) 319 (2008), 1391–1394.
91. 91 Ma, Y., Xu, Y., Yestrepsky, B.D., et al. Novel inhibitors of Staphylococcus aureus virulence gene expression and biofilm formation. PLoS ONE, 7, 2012, e47255.
92. 92 Schwechter, E.M., Folk, D., Varshney, A.K., Fries, B.C., Kim, S.J., Hirsh, D.M., Optimal irrigation and debridement of infected joint implants: an in vitro methicillin-resistant Staphylococcus aureus biofilm model. J Arthroplasty 26 (2011), 109–113.
93. 93 Li, B., Jiang, B., Dietz, M.J., Smith, E.S., Clovis, N.B., Rao, K.M., Evaluation of local MCP-1 and IL-12 nanocoatings for infection prevention in open fractures. J Orthop Res 28 (2010), 48–54.
94. 94 Choe, H., Narayanan, A.S., Gandhi, D.A., et al. Immunomodulatory peptide IDR-1018 decreases implant infection and preserves osseointegration. Clin Orthop Relat Res 473 (2015), 2898–2907.
95. 95 Schafer, P., Fink, B., Sandow, D., Margull, A., Berger, I., Frommelt, L., Prolonged bacterial culture to identify late periprosthetic joint infection: a promising strategy. Clin Infect Dis 47 (2008), 1403–1409.
96. 96 Trampuz, A., Piper, K.E., Jacobson, M.J., et al. Sonication of removed hip and knee prostheses for diagnosis of infection. N Engl J Med 357 (2007), 654–663.
97. 97 Parvizi, J., Fassihi, S.C., Enayatollahi, M.A., Diagnosis of periprosthetic joint infection following hip and knee arthroplasty. Orthop Clin North Am 47 (2016), 505–515.
98. 98 Matsen Ko, L., Parvizi, J., Diagnosis of periprosthetic infection: novel developments. Orthop Clin North Am 47 (2016), 1–9.
99. 99 Lehar, S.M., Pillow, T., Xu, M., et al. Novel antibody-antibiotic conjugate eliminates intracellular S. aureus. Nature 527 (2015), 323–328.